Fengmin Zhang

Prof. Fengmin Zhang

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2023 in Life Sciences
Verified
Journal Article
Closed access
GCGuoding Cao
Guoding Cao
MLMonan Lin
Monan Lin
WGWei Gu
Wei Gu
ZSZaiyu Su
Zaiyu Su
YDYagan Duan
Yagan Duan
FZFengmin Zhang
Fengmin Zhang

1 February 2018 in Journal of Clinical Virology
Verified
Journal Article
Closed access
HHHongxin Huang
Hongxin Huang
JWJie Wang
Jie Wang
WLWeijie Li
Weijie Li
RCRan Chen
Ran Chen
XCXiangmei Chen
Xiangmei Chen
FLFengmin Lu
Fengmin Lu

1 April 2018 in Molecular Immunology
Verified
Journal Article
Closed access
XCXiaohang Chen
Xiaohang Chen
BYBingqing Yan
Bingqing Yan
HLHuihuang Lou
Huihuang Lou
ZSZhenji Shen
Zhenji Shen
FTFangjia Tong
Fangjia Tong
FZFengmin Zhang
Fengmin Zhang

1 January 2019 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
RNRose Magoma Nyamao
Rose Magoma Nyamao
JWJing Wu
Jing Wu
LYLi Yu
Li Yu
XXXiao Xiao
Xiao Xiao
FZFengmin Zhang
Fengmin Zhang

1 December 2017 in Autoimmunity Reviews
Verified
Journal Article
Closed access
JWJing Wu
Jing Wu
XLXiaobo Li
Xiaobo Li
WSWuqi Song
Wuqi Song
YFYong Fang
Yong Fang
LYLi Yu
Li Yu
FZFengmin Zhang
Fengmin Zhang

8 August 2016 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
WCWenhui Cai
Wenhui Cai
YFYingmei Fu
Yingmei Fu
WZWenli Zhang
Wenli Zhang
XCXiaobei Chen
Xiaobei Chen
JZJizi Zhao
Jizi Zhao
FZFengmin Zhang
Fengmin Zhang
Generation of extended- spectrum β- lactamases is one of the major mechanisms by which clinical Klebsiella pneumoniae develop resistance to antibiotics. Combined antibiotics prove to be a relatively effective method of controlling such resistant strains. Some of Chinese herbal active ingredients are known to have synergistic antibacterial effects. This study is aimed to investigate synergistic effects of Chinese herbal active ingredients with cefotaxime on the extended- spectrum β- lactamase positive strains of Klebsiella pneumoniae, and to analyze mechanism of synergistic action, providing experimental evidence for clinical application of antimicrobial drugs. For total sixteen strains including fifteen strains of cefotaxime resistant K. pneumoniae and one extended- spectrum β- lactamase positive standard strain, the synergy rates of cefotaxime with baicalein, matrine, and clavulanic acid were 56.3 %, 0 %, and 100 %, respectively. The fractional inhibitory concentration index of combined baicalein and cefotaxime was correlated with the percentage decrease of cefotaxime MIC of all the strains (r = −0.78, p <0.01). In the group of synergy baicalein and cefotaxime, the transcribed mRNA level of CTX-M-1 after treatment of baicalein was decreased significantly (p <0.05). Moreover, the CTX-M-1 mRNA expression percentage inhibition (100 %, 5/5) was significantly higher than non- synergy group (25 %, 1/4) (p <0.05). Our study demonstrated that baicalein exhibited synergistic activity when combined with cefotaxime against some of extended- spectrum β- lactamases positive K. pneumoniae strains by inhibiting CTX-M-1 mRNA expression. However, no direct bactericidal or bacteriostatic activity was involved in the synergistic action. Baicalein seems to be a promising novel effective synergistic antimicrobial agent.